1. Adadey, Samuel M, Esoh, Kevin K, Quaye, Osbourne, Awandare, Gordon A, Wonkam, Ambroise. 2020. GJB4 and GJC3 variants in non-syndromic hearing impairment in Ghana. In Experimental biology and medicine (Maywood, N.J.), 245, 1355-1367. doi:10.1177/1535370220931035. https://pubmed.ncbi.nlm.nih.gov/32524838/
2. Liu, GuiYuan, Pang, Yi, Zhang, YaJun, Xiong, Wei, Zhang, YongHui. 2019. GJB4 promotes gastric cancer cell proliferation and migration via Wnt/CTNNB1 pathway. In OncoTargets and therapy, 12, 6745-6755. doi:10.2147/OTT.S205601. https://pubmed.ncbi.nlm.nih.gov/31692499/
3. Lin, Yi-Pei, Wu, Jun-I, Tseng, Chien-Wei, Chen, Huei-Jane, Wang, Lu-Hai. 2018. Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation. In Oncogene, 38, 822-837. doi:10.1038/s41388-018-0471-1. https://pubmed.ncbi.nlm.nih.gov/30177841/
4. Lucaciu, Sergiu A, Figliuzzi, Rhett, Neumann, Ruth, Bai, Donglin, Laird, Dale W. 2023. GJB4 variants linked to skin disease exhibit a trafficking deficiency en route to gap junction formation that can be restored by co-expression of select connexins. In Frontiers in cell and developmental biology, 11, 1073805. doi:10.3389/fcell.2023.1073805. https://pubmed.ncbi.nlm.nih.gov/36861039/
5. Gässler, Anneke, Quiclet, Charline, Kluth, Oliver, Schürmann, Annette, Vogel, Heike. 2020. Overexpression of Gjb4 impairs cell proliferation and insulin secretion in primary islet cells. In Molecular metabolism, 41, 101042. doi:10.1016/j.molmet.2020.101042. https://pubmed.ncbi.nlm.nih.gov/32565358/
6. de Oliveira, Renan Tironi G, Christofolini, Denise Maria, Criado, Paulo R, Kelsell, David, Machado Filho, Carlos D'Apparecida Santos. 2020. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree. In International journal of dermatology, 59, 722-725. doi:10.1111/ijd.14894. https://pubmed.ncbi.nlm.nih.gov/32311086/
7. Muramatsu, Joji, Arihara, Yohei, Yoshida, Makoto, Kobune, Masayoshi, Takada, Kohichi. 2024. Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. In Cancer science, 115, 1564-1575. doi:10.1111/cas.16101. https://pubmed.ncbi.nlm.nih.gov/38342100/
智鼠故事 
